Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial
Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, David J. Sas, Mini Michael, Anne Laure Sellier-Leclerc, Julien Hogan, Richard Willey, John M. Gansner, Daniella Magen
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial'. Together they form a unique fingerprint.